1. Dose reduction of docetaxel avoids the usage of pegfilgrastim in docetaxel plus ramucirumab therapy for recurrent nonsmall cell lung cancer. Issue 4 (2nd February 2023) Authors: Hamai, Kosuke; Miyaka, Shinya; Tada, Shinpei; Fujita, Suguru; Hirakawa, Tetsu; Matsumura, Mirai; Ueno, Sayaka; Tanimoto, Takuya; Ishikawa, Nobuhisa Journal: Cancer reports Issue: Volume 6:Issue 4(2023) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Efficacy of erlotinib and its effects on the quality of life of older patients with epidermal growth factor receptor‐mutant non‐small cell lung cancer: A prospective, multicenter, dose‐modification study. Issue 10 (10th August 2021) Authors: Tsubata, Yukari; Masuda, Takeshi; Hamai, Kosuke; Taniwaki, Masaya; Tanino, Akari; Hotta, Takamasa; Hamaguchi, Megumi; Hamaguchi, Shunichi; Yamasaki, Masahiro; Ishikawa, Nobuhisa; Fujitaka, Kazunori; Sutani, Akihisa; Isobe, Takeshi Journal: Geriatrics and gerontology international Issue: Volume 21:Issue 10(2021) Page Start: 881 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. First‐line immune checkpoint therapy in metastatic squamous cell lung cancer harboring both EGFR mutation and high expression of PD‐L1: A case report. Issue 6 (14th April 2020) Authors: Hamai, Kosuke; Tanahashi, Hiroki; Ueno, Sayaka; Konishi, Hanae; Matsumura, Mirai; Nomura, Akio; Nakamoto, Kanako; Isoyama, Shoko; Tanimoto, Takuya; Shoda, Hiroyasu; Ishikawa, Nobuhisa Journal: Thoracic cancer Issue: Volume 11:Issue 6(2020) Page Start: 1716 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Gemcitabine maintenance therapy after gemcitabine and platinum drug chemotherapy for naive stage IIIB/IV squamous cell lung cancer: a phase II study. Issue 7 (6th May 2021) Authors: Hamai, Kosuke; Fujitaka, Kazunori; Kitaguchi, Soichi; Tamamoto, Seika; Takao, Shun; Nishida, Ayako; Furutama, Junko; Horimasu, Yasushi; Masuda, Takeshi; Miyamoto, Shintaro; Awaya, Yoshikazu; Kondo, Tomohiro; Shoda, Hiroyasu; Ishikawa, Nobuhisa; Yamasaki, Masahiro; Hattori, Noboru Journal: Anti-cancer drugs Issue: Volume 32:Issue 7(2021) Page Start: 767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Gemcitabine maintenance therapy after gemcitabine and platinum drug chemotherapy for naive stage IIIB/IV squamous cell lung cancer: a phase II study. Issue 7 (August 2021) Authors: Hamai, Kosuke; Fujitaka, Kazunori; Kitaguchi, Soichi; Tamamoto, Seika; Takao, Shun; Nishida, Ayako; Furutama, Junko; Horimasu, Yasushi; Masuda, Takeshi; Miyamoto, Shintaro; Awaya, Yoshikazu; Kondo, Tomohiro; Shoda, Hiroyasu; Ishikawa, Nobuhisa; Yamasaki, Masahiro; Hattori, Noboru Journal: Anti-cancer drugs Issue: Volume 32:Issue 7(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Incidence of venous thromboembolism in advanced lung cancer and efficacy and safety of direct oral anticoagulants: a multicenter, prospective, observational study (Rising-VTE/NEJ037 study). (July 2022) Authors: Tsubata, Yukari; Hotta, Takamasa; Hamai, Kosuke; Furuya, Naoki; Yokoyama, Toshihide; Saito, Ryota; Nakamura, Atsushi; Masuda, Takeshi; Hamaguchi, Megumi; Kuyama, Shoichi; Honda, Ryoichi; Senoo, Tadashi; Nakanishi, Masamoto; Yamasaki, Masahiro; Ishikawa, Nobuhisa; Fujitaka, Kazunori; Kubota, Tetsu... Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Osimertinib versus osimertinib plus chemotherapy for non–small cell lung cancer with EGFR (T790M)-associated resistance to initial EGFR inhibitor treatment: An open-label, randomised phase 2 clinical trial. (May 2021) Authors: Tanaka, Kentaro; Asahina, Hajime; Kishimoto, Junji; Miyata, Yoshihiro; Uchida, Takahiro; Watanabe, Kana; Hamai, Kosuke; Harada, Taishi; Tsubata, Yukari; Sugawara, Shunichi; Kobayashi, Kunihiko; Sugio, Kenji; Oizumi, Satoshi; Okamoto, Isamu Journal: European journal of cancer Issue: Volume 149(2021) Page Start: 14 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Phase 2 study of first‐line pembrolizumab monotherapy in elderly patients with non‐small‐cell lung cancer expressing high PD‐L1. Issue 11 (30th April 2022) Authors: Masuda, Takeshi; Fujitaka, Kazunori; Suzuki, Tomoko; Hamai, Kosuke; Matsumoto, Naoko; Matsumura, Mirai; Isoyama, Shoko; Ueno, Sayaka; Mito, Mineyo; Yamaguchi, Kakuhiro; Sakamoto, Shinjiro; Kawano, Reo; Masuda, Ken; Nishino, Ryohei; Ishikawa, Nobuhisa; Yamasaki, Masahiro; Hattori, Noboru Journal: Thoracic cancer Issue: Volume 13:Issue 11(2022) Page Start: 1611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Use of proton pump inhibitors is associated with increased mortality due to nosocomial pneumonia in bedridden patients receiving tube feeding. Issue 8 (22nd May 2018) Authors: Hamai, Kosuke; Iwamoto, Hiroshi; Ohshimo, Shinichiro; Wakabayashi, Yu; Ihara, Daisuke; Fujitaka, Kazunori; Hamada, Hironobu; Ono, Koichi; Hattori, Noboru Journal: Geriatrics and gerontology international Issue: Volume 18:Issue 8(2018) Page Start: 1215 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗